研究表明，与接受安慰剂的患者相比，接受西布曲明患者例如心脏病发作和中风等心脏问题风险增加16%。
Patients given Meridia had a 16 percent increased risk of heart problems such as heart attack or stroke compared to those given a placebo, the study showed.
星期三发表的所谓SCOUT研究的最终数据表明西布曲明增加已患心脏病的患者的心脏病发作和中风的风险。
Final data from the so-called SCOUT study, published on Wednesday, showed Meridia increases the risk of heart attacks and strokes in patients who already have heart disease.
目的：评价西布曲明治疗单纯性肥胖病的临床疗效和安全性，并比较西布曲明和安慰剂对静息代谢率的影响。
Objective to evaluate the clinical therapeutic efficacy and safety of sibutramine to simple obesity and compare the effects of sibutramine and placebo on resting metabolic rate.
应用推荐